RETRACTED ARTICLE: BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway

[1] Starley BQ(2010)Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology. 51 1820-1832

[2] Calcagno CJ(2010)Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting J Clin Oncol 28 3994-4005

[3] Harrison SA(2014)Hepatocellular carcinoma: clinical frontiers and perspectives Gut. 63 844-855

[4] Thomas MB(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology. 142 1264-73 e1

[5] Bruix J(2011)Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method Anal Bioanal Chem 401 1899-1904

[6] Gores GJ(2014)Role of antiviral treatment for HCC prevention Best Pract Res Clin Gastroenterol 28 771-781

[7] Mazzaferro V(2015)Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches Gut. 64 842-848

[8] El-Serag HB(2010)Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma Gastroenterology. 139 2146-57 e12

[9] Chen F(2014)Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases Int J Mol Sci 15 5199-5220

[10] Colombo M(2012)Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma Pathol Oncol Res 18 635-640

[1] Starley BQ(2010)Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology. 51 1820-1832

[2] Calcagno CJ(2010)Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting J Clin Oncol 28 3994-4005

[3] Harrison SA(2014)Hepatocellular carcinoma: clinical frontiers and perspectives Gut. 63 844-855

[4] Thomas MB(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology. 142 1264-73 e1

[5] Bruix J(2011)Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method Anal Bioanal Chem 401 1899-1904

[6] Gores GJ(2014)Role of antiviral treatment for HCC prevention Best Pract Res Clin Gastroenterol 28 771-781

[7] Mazzaferro V(2015)Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches Gut. 64 842-848

[8] El-Serag HB(2010)Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma Gastroenterology. 139 2146-57 e12

[9] Chen F(2014)Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases Int J Mol Sci 15 5199-5220

[10] Colombo M(2012)Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma Pathol Oncol Res 18 635-640